Plain-English translation of NCT06808633 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a procedure called Direct Selective Laser Trabeculoplasty (DSLT) to see if it can lower the pressure inside your eyes and help control glaucoma. The treatment uses a special laser to target a tiny area inside your eye that controls fluid drainage. Researchers want to find out whether this laser treatment works well in real clinical practice and how much it can reduce eye pressure.
Glaucoma damages the eye's optic nerve, often because fluid pressure builds up inside the eye. This treatment exists because doctors are looking for effective ways to lower eye pressure without requiring patients to take daily medications, which some people struggle to use consistently.
You likely qualify if…
You likely don't qualify if…
You will receive the laser treatment on your first visit, where your eye pressure will be measured before the procedure. After that, you will return for follow-up visits at 1 week, 1 month, 3 months, 6 months, and 12 months to have your eye pressure checked again and to tell your doctor about any side effects you may have noticed. The study lasts one year total, and the main focus is measuring how much your eye pressure drops six months after treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Spain